Completed PHASE2 INTERVENTIONAL 2-arm NCT01172171

The Effect of Melatonin on Ischemia-reperfusion Injury Following Acute Myocardial Infarction

Intracoronary Injection of Melatonin for Patients With ST-elevation Myocardial Infarction: a Placebo Controlled Randomized Study

Sponsor: Herlev Hospital

Conditions Acute Myocardial Infarction Ischemia-reperfusion Injury

Interventions Isotonic saline, Natrium chloride Melatonin, N-acetyl-5-methoxytryptamine

Updated 5 times since 2017 Last updated: Jan 3, 2017 Started: Jun 30, 2013 Primary completion: Jun 30, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01172171, this PHASE2 trial focuses on Acute Myocardial Infarction and Ischemia-reperfusion Injury and remains completed. Sponsored by Herlev Hospital, it has been updated 5 times since 2013, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Herlev Hospital

Data source: Herlev Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalborg, Denmark
• Odense, Denmark